Corsmed, founded in 2016 in Sweden, is redefining Magnetic Resonance Imaging (MRI) with its cutting-edge simulation platform. Commonly dubbed the "Flight simulator of MR", this innovative startup focuses on enhancing patient health and safety on a global scale.
In its mission to revolutionize the healthcare sector, Corsmed has developed what is considered the most proficient MRI simulation tool in the world. This platform offers significant potential for improving medical diagnostics and training practices, providing a safer, more efficient alternative to traditional methods.
The company most recently secured a $3.50M Seed investment on 01 January 2025, backed by prominent investors Luminar Ventures and Big Pi Ventures. This financial support underscores the confidence in Corsmed's capacity to drive transformative changes in the healthcare industry and highlights its potential for long-term growth and scalability.